The oncofetal antigen (HGR-Ag) in brain tumors was newly defined using the monoclonal antibody derived from tissue extracts of an anaplastic astrocytoma. The HGR-Ag was purified through sequen tial chromatography using diethylaminoethyl-Sephadex A-50 and Con-A Sepharose affinity columns. The latter method indicated that HGR-Ag is not a glycoprotein, and Western blot analysis indicated a molecular weight of 80-90 kd. Purified antigen was used to produce antibody. This new antibody, designated H1H2, was shown to be an immunoglobulin G1 by immunodiffusion assay.<BR> &nbsp; Histological&frasl;immunohistochemical studies using the H1H2 antibody on paraffin and frozen tissue sections showed HGR-Ag to be intracellular rather than membrane-associated.
Introduction
Several monoclonal antibodies (MoAbs) directed at glioma antigens with cross reactivity to gliomas have been reported."',"," ' However, no pure MoAb directed specifically to glioma has yet been estab lished, making clinical applications difficult. How ever, the use of MoAbs has yielded much informa tion on the biochemistry of malignant tumor cells. Recently, two main clinical approaches to the use of MoAbs have emerged. In immunotherapy, the antibody can damage tumor cells through the im munological response as well as through the direct chemotherapeutic effects of attached anti-tumor agents. '"') In immunohistochemical investigation, the antibody is useful in the diagnosis of tumors that Aliquots (100 pg) of each fraction containing 300,ug of protein were analyzed using 7.5% polyacrylamide gel. Gels were examined to identify bands present in the tumor preparations but not in preparations from normal adult brain tissue. The fraction of the astrocytoma supernatant containing HGR-Ag was further purified using Sephadex G-100 and Con-A Sepharose column chromatography to characterize the antigen.
II. Production of MoAbs
Balb/c male mice were given subcutaneous injec tions of the purified HGR-Ag (424µg) suspended in Freund's complete adjuvant (0.4 ml). Seven days later, individuals received an intraperitoneal injec tion of 1060,ug HGR-Ag. Seven days after this, a sec ond intraperitoneal injection of 212,ug antigen was given. Three days after the third injection, the mice were killed and the splenocytes were harvested. P3X63Ag8.653 mouse myeloma cells (1.0 X 107) were incubated with mouse immune splenocytes (1.0 X 108) in 0.3 ml of 40% polyethylene glycol 1540 for 3 minutes at 37'C.") The resulting cells were seeded into microtiter plates at 1 X 105 cells per well and grown in culture medium (hypoxantine 1.0 X 104 mol/l, aminopterin 1.0 x 10-5 mol/l, thy midine 4.0 x 10-5 mol/1) for selection of hybrido mas. Two weeks after the fusion procedure, super natants from each well were analyzed for antibody by the avidin-biotin complex (ABC) immunoperox idase technique. Cells were diluted and expanded (3 cycles) to ensure homogeneity of the selected clones of hybridoma cells. Balb/c mice were then injected with the hybridomas for production of ascites fluids. The resulting ascites were purified using a Sephacryl S-300 column equilibrated with phos phate-buffered saline. The purity and specificity of the antibody was determined using the Ouchterlony immunodiffusion assay.
III. Tissue samples
Samples from various brain tumors, malignant tumors of other organs, and normal adult and fetal brain tissue were fixed in 10% buffered formalin and embedded in paraffin. Brain tumor tissues, stored at -80°C until use , were fixed in periodate-lysine paraformaldehyde solution and immersed in OCT medium (Miles Co., Eikhart, Ind., U.S.A.)." Glioma cell lines, SK-MG-1 and SK-MG-4, were cultured for 4 days in tissue culture chamber slides (4802; Miles Co.), then fixed in 50% methanol and 50% acetone. These slides, and those prepared from fro zen sections, were used for immunohistochemical studies.
IV. Immunohistochemical staining Immunohistochemical staining used the ABC method according to the manufacturer's protocol (Vectastain ABC kit; Vecta Lab. Co., Ltd., Bur lingame, Cal., U.S.A.). Briefly, MoAb, diluted at 1:200-1:500, was incubated with the tissue for 1 hour at room temperature.
The tissue samples were next incubated with biotinylated secondary anti body, then with performed avidin-biotin horse radish peroxidase complex. Antigen was localized by incubation in a peroxidase substrate solution. identified a band associated with the tumor (HGR-Ag) in the third and fourth fractions (Fig. 1) . The fourth fraction was apparently purer and contained more HGR-Ag. Further chromatog raphy of this fraction using the Sephadex G-100 column achieved no adequate separation of the proteins (data not shown). Therefore, the entire protein-containing band was passed through a Con A Sepharose column, yielding three protein frac tions. Only the second fraction contained HGR-Ag by SDS-PAGE analysis (Fig. 2) . Addition of 1-0 methyl-a-D-glucopyranoside indicated that the an tigen was not a glycoprotein. Western blot analysis showed the molecular weight (MW) of this HGR-Ag to be 85 kd. This fraction was used as the im munogen for production of immune splenocytes in Balb/c mice. Antibody H 1 H2 was obtained follow ing fusion of immune splenocytes and mouse myeloma P3X63Ag8.653 cells as described previous ly. II. Characterization of H1H2 Ouchterlony immunodiffusion assay showed the ascites-derived MoAb H 1 H2 to be immunoglobulin G1. Immunohistochemical studies showed that H 1 H2 reacted specifically with cytoplasmic com ponents or interstitial tissues in tumors (Fig. 3) . In paraffin sections of brain tumors, the immunoreac tivities of astrocytoma grades I and II, astrocytoma grades III and IV, and glioblastoma were 45, 85, and 90% positive staining, respectively (Table 1) . The data also indicated that the reactivity of H 1 H2 to gliomas was positively correlated with malignancy. Thus, although neurinomas demonstrated some reac tivity, no medulloblastoma or ependymoma tested ex hibited a positive reaction. H 1 H2 binding in frozen brain tumor sections generally corresponded to that in paraffin sections. Among malignant tumors in other organs, some hepatomas and small cell car cinomas showed positive antibody-mediated stain ing, but most tumors did not ( (Fig. 4) . With the exception of fetal brain tissue, normal human adult and fetal tissues were non-reactive (Table 3) .
III. SDS-PAGE analysis of human gliomas Four of the five gliomas examined contained HGR-Ag, shown by the band at the appropriate MW (Fig. 5) . These four gliomas showed positive H 1 H2 mediated immunohistochemical staining, while the fifth glioma was negative.
Therefore, the im munohisto chemical analysis was corroborated by the SDS-PAGE analysis, showing the accuracy of the ABC technique. 
Discussion
The use of MoAbs to study the central nervous system (CNS) has yielded much information on CNS differentiation, differential diagnosis and microbiol ogy of CNS pathology, particularly of CNS tu mors. Antigens expressed by CNS tumors, especial ly gliomas, are usually in one of four categories: 1) normal CNS-associated antigens,",")
2) shared neural/lymphoid antigens, 3) neuroectodermal oncofetal antigens, or 4) putative tumor-specific an tigens .9,25) At present, the most widely used tumor markers for immunohistochemical studies are MoAbs or polyclonal antisera directed against glial fibrillary acidic protein (GFAP)3"" ) and neuron specific enolase,4'20) all considered normal CNS-asso ciated antigens and components of cell cytoplasm. 
